We designed the EURAMOS-1 trial to investigate whether intensified .. and a normal creatinine concentration for their age as per protocol. EURAMOS-1, an international randomised study for osteosarcoma: Results from Pre-operative chemotherapy was completed according to protocol in 94%. The EURAMOS 1 trial is a multimodal therapy of osteosacoma with precluding treatment with protocol chemotherapy (for example HIV.
|Genre:||Health and Food|
|Published (Last):||25 November 2007|
|PDF File Size:||14.40 Mb|
|ePub File Size:||10.23 Mb|
|Price:||Free* [*Free Regsitration Required]|
Considerable regulatory, financial and operational challenges must be overcome to develop similar studies in the future. Osteosarcoma therapy was revolutionised by the introduction of adjuvant combination chemotherapy, in the s, eiramos has improved little since. Standard descriptive statistics are used.
While the link between increased toxicity and improved survival from osteosarcoma remains to be unravelled [ 26 ], future approaches must look to reduce this burden as well as improve efficacy.
This article has been cited by other articles in PMC. The primary outcome measure was event-free survival EFS eyramos, defined as time from randomisation to the protcol of: J Natl Cancer Inst. Randall35 P. Kager25 T.
Ifosfamide and etoposide in childhood osteosarcoma. Longitudinal evaluation of quality of life was undertaken. Commencing Marchpatients were registered from centres across 17 countries. Cancer Protlcol Evaluation Program. Good histological response, assessed in the resected tumour, has been associated with improved survival [ 3 — 5 ]. It assessed maintenance therapy in patients with a better prognosis Good Response [ 19 ] and intensification in patients with poorer prognosis Poor Response [ 920 — 22 ].
Median time from surgery to starting post-operative chemotherapy for randomised patients was 18 days IQR 14; Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: Four international study groups undertook a large study in resectable osteosarcoma, which included two randomised controlled trials, to determine the effect on survival of changing post-operative chemotherapy based on histological response.
Funding Medical Research Council.
Page Not Found
Butterfass-Bahloul9 T. Quality of life in children and adolescents with cancer. Published online Nov Surgery will be performed after 10 weeks of pre-operative chemotherapy.
Whelan1 S. Cure of osteosarcoma in a proportion of patients was consistently reported first in the s, achieved through the combination of surgical extirpation of the primary tumour with multi-drug chemotherapy. Read Article at publisher’s site.
Page Not Found | MRC Clinical Trials Unit at UCL
Uniform response of metastases eurzmos high dose ifosfamide. CitePeer Related Articles http: At the time of trial planning, few data were available to guide a sample size calculation to accurately estimate randomisation rates and these were markedly lower than expected, which contributed to a decision to expand registration targets from to over Click here to view.
Hogendoorn8 G. Data collection including registration characteristics and reports on pre-operative chemotherapy, surgery and pathology had to be received by the randomising data centre.
We were unable to open EURAMOS-1 in some countries that eurammos to participate either because euramks regulatory constraints or insufficient funding. There was some variability in proportion randomised between groups: Concordance with protocol chemotherapy was excellent. Pathology at diagnostic biopsy and surgery. Consent was obtained according to national regulations.
University Hospital of Muenster, Muenster, Germany.